Advertisement

Transcatheter Pulmonary Valve Replacement

  • Hussam S. SuradiEmail author
  • Ziyad M. Hijazi
Chapter
  • 10 Downloads

Abstract

Percutaneous pulmonary valve implantation (PPVI) has the distinction of being the first percutaneous valve replacement in humans, writing a new chapter in cardiac therapeutics with the development of transcatheter valve technologies. This innovation has evolved as an attractive alternative to surgery and has allowed treatment of a growing patient population with congenital heart disease, minimizing the number of lifetime sternotomies and extending the life of previously implanted conduits. Since the introduction of this technology in 2000, several clinical trials have demonstrated effective restoration of valvular competence with excellent outcomes; transforming this technology from its early pioneering nature into routine clinical care at specialized centers.

Keywords

Melody® valve Percutaneous pulmonary valve implantation Pulmonary regurgitation Right ventricular outflow tract Transcatheter pulmonary valve replacement 

References

  1. 1.
    Holst KA, Dearani JA, Burkhart HM, et al. Risk factors and early outcomes of multiple reoperations in adults with congenital heart disease. Ann Thorac Surg. 2011;92:122–8.CrossRefGoogle Scholar
  2. 2.
    Boethig D, Thies WR, Hecker H, Breymann T. Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and Contegras. Eur J Cardiothorac Surg. 2005;27:58–66.CrossRefGoogle Scholar
  3. 3.
    Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–5.CrossRefGoogle Scholar
  4. 4.
    McElhinney DB, Hellenbrand WE, Zahn EM, Jones TK, Cheatham JP, Lock JE, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US Melody valve trial. Circulation. 2010;122:507–16.CrossRefGoogle Scholar
  5. 5.
    Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117:1964–72.CrossRefGoogle Scholar
  6. 6.
    Asoh K, Walsh M, Hickey E, et al. Percutaneous pulmonary valve implantation within bioprosthetic valves. Eur Heart J. 2010;31:1404–9.CrossRefGoogle Scholar
  7. 7.
    Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112:1189–97.CrossRefGoogle Scholar
  8. 8.
    Lurz P, Puranik R, Nordmeyer J, et al. Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur Heart J. 2009;30:2266–74.CrossRefGoogle Scholar
  9. 9.
    Batra AS, McElhinney DB, Wang W, et al. Cardiopulmonary exercise function among patients undergoing transcatheter pulmonary valve implantation in the US Melody valve investigational trial. Am Heart J. 2012;163:280–7.CrossRefGoogle Scholar
  10. 10.
    Plymen CM, Bolger AP, Lurz P, et al. Electrical remodeling following percutaneous pulmonary valve implantation. Am J Cardiol. 2011;107:309–14.CrossRefGoogle Scholar
  11. 11.
    Chapron JAH, Theodoropoulos S, Kalantzi M, Yacoub M, Torii R. Quantitative assessment of right ventricular structure and flow dynamics in pulmonary homograft obstruction. Glob Cardiol Sci Pract. 2014;2014:350–3.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Feltes TF, Bacha E, Beekman RH 3rd, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2607–52.CrossRefGoogle Scholar
  13. 13.
    Kenny D, Hijazi ZM, Kar S, Rhodes J, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58:2248–56.CrossRefGoogle Scholar
  14. 14.
    Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975–81.CrossRefGoogle Scholar
  15. 15.
    Broberg CS, Aboulhosn J, Mongeon FP, et al. Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of fallot. Am J Cardiol. 2011;107:1215–20.CrossRefGoogle Scholar
  16. 16.
    Guccione P, Milanesi O, Hijazi ZM, Pongiglione G. Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards SAPIEN transcatheter heart valve. Eur J Cardiothorac Surg. 2012;41:1192–4.CrossRefGoogle Scholar
  17. 17.
    Cheatham SL, Holzer RJ, Chisolm JL, Cheatham JP. The Medtronic Melody(R) transcatheter pulmonary valve implanted at 24-mm diameter—it works. Catheter Cardiovasc Interv. 2013;82:816–23.CrossRefGoogle Scholar
  18. 18.
    Bergersen L, Benson LN, Gillespie MJ, et al. Harmony feasibility trial: acute and short-term outcomes with a self-expanding transcatheter pulmonary valve. JACC Cardiovasc Interv. 2017;10:1763–73.CrossRefGoogle Scholar
  19. 19.
    Morray BH, McElhinney DB, Cheatham JP, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013;6:535–42.CrossRefGoogle Scholar
  20. 20.
    Sridharan S, Coats L, Khambadkone S, Taylor AM, Bonhoeffer P. Images in cardiovascular medicine. Transcatheter right ventricular outflow tract intervention: the risk to the coronary circulation. Circulation. 2006;113:e934–5.CrossRefGoogle Scholar
  21. 21.
    Eicken A, Ewert P, Hager A, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;32:1260–5.CrossRefGoogle Scholar
  22. 22.
    Butera G, Milanesi O, Spadoni I, et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Catheter Cardiovasc Interv. 2013;81:310–6.CrossRefGoogle Scholar
  23. 23.
    McElhinney DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6:292–300.CrossRefGoogle Scholar
  24. 24.
    Cheatham JP, Hellenbrand WE, Zahn EM, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US Melody valve investigational device exemption trial. Circulation. 2015;131:1960–70.CrossRefGoogle Scholar
  25. 25.
    Cao QL, Kenny D, Zhou D, et al. Early clinical experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv. 2014;84:1131–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Structural Hybrid Lab, Division of Cardiovascular Medicine, Rush Center for Structural Heart DiseaseRush University Medical CenterChicagoUSA
  2. 2.Community HospitalMunsterUSA
  3. 3.Sidra Heart CenterSidra MedicineDohaQatar

Personalised recommendations